A breakthrough in breast cancer screening is being hailed as a major step forward in the fight against womankind's most common form of cancer. Several NHS hospitals are preparing to use an AI-powered blood test to help assess women referred for possible womb cancer before invasive checks are carried out. According to The Guardian, around 90,000 postmenopausal women in England are referred by general practitioner GPs each year after experiencing heavy bleeding.
The AI-powered blood test is based on the analysis of a woman's blood profile and has been shown to be accurate in detecting early signs of womb cancer. Once it has identified potential issues, the patient will receive instructions on whether they require an invasive check or can opt for a non-invasive screening like a pelvic exam instead.
The NHS AI blood test is seen as a significant improvement over traditional methods, which involve more invasive procedures and carry a higher risk of complications. According to The Guardian, by using AI-powered testing, women will be able to receive targeted care that is both effective and minimizes the risk of harm. This new approach is expected to benefit thousands of women each year and help reduce the number of people being diagnosed with womb cancer unnecessarily.